ClinicalTrials.gg
CompletedNCT02118233Updated Nov 26, 2019

Cognitive Outcome After Carotid Surgery

An observational study in Carotid Stenosis, sponsored by Lahey Clinic. Completed at 3 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-11-26.

Sponsored by Lahey Clinic · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
56
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to understand how carotid endarterectomy (CEA) or percutaneous carotid angioplasty and stenting (CAS) affect memory and thinking resulting in improving or worsening of thinking or memory. There have been many studies on this subject, some finding that certain patients gain improvement in their brain function and others might get worse. The goal of this study is to discover which patients are more likely to have improved cognitive functioning. Carotid endarterectomy (CEA) and percutaneous carotid angioplasty and stenting (CAS) are not investigational and are an accepted treatment for your condition. In addition, subjects that choose not to undergo surgery will also be included in this study.

Read the detailed description

At the present time, large multi-center clinical trials support the use of carotid revascularization for symptomatic carotid stenosis and for asymptomatic carotid stenosis (greater than 60%) to prevent stroke. Guidelines supporting the use of carotid endarterectomy for asymptomatic stenosis are based largely on the Asymptomatic Carotid Atherosclerosis Study (ACAS) which reported a 47% relative risk reduction for ipsilateral stroke or death in patients randomized to surgery compared to best medical management over 5 years. These data were further substantiated by the recent publication of the Medical Research Council Asymptomatic Carotid Surgery (ACST) trial results (1); however, both trials estimated that at least 40 operative procedures were required to prevent a single disabling stroke or death in one patient after 5 years (2). These data underscore the importance of understanding the cognitive risks of carotid revascularization and developing strategies to limit factors that contribute to this risk especially in asymptomatic patients.

The purpose of this study is to better understand the effect of carotid revascularization (using either carotid endarterectomy (CEA) or percutaneous carotid angioplasty and stenting (CAS)) on cognitive outcome by prospectively collecting cerebral blood flow data and cognitive testing data prior to and after carotid revascularization procedures.

02

Conditions studied

  • Carotid Stenosis

Keywords

  • carotid
  • stenosis
  • surgery
  • cognitive
  • unilateral
03

In context

Carotid Stenosis

349 studies on the registry are indexed under Carotid Stenosis; 82 are open to participants now.

This study's planned enrollment of 56 is below the median of 175 across 147 observational studies indexed under Carotid Stenosis.

Browse Carotid Stenosis studies →

Lead sponsor

Lahey Clinic is the lead sponsor of 61 studies on the registry; 4 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients with unilateral, asymptomatic, significant carotid artery stenosis who are ≥18 years of age who do not present with past or current significant cerebrovascular and neuropsychological disease.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with asymptomatic (defined as no symptoms in past 6 months) carotid stenosis
  • Patients with hemodynamically significant carotid artery stenosis (according to CREST criteria: ≥ 60% by angiography, OR ≥ 70% by ultrasound, OR ≥ 80% by CTA or MRA)

Exclusion criteria

Exclusion Criteria:

  • Patients with prior large vessel infarct
  • Patients with intracranial stenosis
  • Patients with major depression
  • Patients with Alzheimer disease (clinically defined or Wechsler IQ \<80)
  • Patients who have had previous ipsilateral carotid surgery
  • Patients with baseline dementia defined as: Mini-Mental Status Examination score \< 21 OR Mini-Mental score ≥21 AND Baseline HVLT scores more than 3 standard deviations below normal or FAS scores more than 2 standard deviations below normal OR other clinical symptoms that were not as evident on direct cognitive assessment (e.g. sundowning, getting lost while driving).

Note: A control group would be comprised of about 15 patients who meet eligibility criteria as above, but elect to have their condition followed rather than undergo revascularization.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
56 participants (estimated)
Patient registry
No

Groups and cohorts

  • Carotid Endarterectomy (CEA)

    Surgical Revascularization- Carotid Endarterectomy (CEA)

  • Carotid Angioplasty and Stenting (CAS)

    Surgical Revascularization- Carotid Angioplasty and Stenting (CAS)

  • Control Group- Medical Management

    Control Group- Medical Management

06

What researchers measure

Primary outcomes

  1. Measurement of change in cerebral blood flow from pre-op/baseline to 1 month post-operatively.

    Quantitative flow MRA studies will be performed pre-operative and postoperative for those undergoing carotid revascularization surgery. Those not undergoing surgery will have this test upon study enrollment and approximately 1 month from study enrollment date.

    Time frame: preoperative/baseline and 1 month postoperative/from baseline

Secondary outcomes

  1. Mini Mental Status Exam

    A standardized cognitive measure

    Time frame: Pre-operative/baseline

  2. Trail Making- Part A

    Standardized cognitive measure that assesses verbal fluency

    Time frame: Preoperative/baseline, 1 month postoperative/post baseline, 6 months postoperative/post baseline, and 1 year postoperative/post baseline

  3. Trail Making- Part B

    Standardized cognitive measure that assesses executive functioning

    Time frame: Preoperative/baseline, 1 month postoperative/post baseline, 6 months postoperative/post baseline, and 1 year postoperative/post baseline

  4. Hopkins Verbal Learning Test (HVLT)

    Standardized measure to assess new learning and memory

    Time frame: Preoperative/baseline, 1 month postoperative/post baseline, 6 months postoperative/post baseline, and 1 year postoperative/post baseline

  5. D-KEFS Verbal Fluency Test (FAS)

    Standardized measure to assess letter fluency

    Time frame: Preoperative/baseline, 1 month postoperative/post baseline, 6 months postoperative/post baseline, and 1 year postoperative/post baseline

07

Study locations

3 sites
  • Lahey Clinic, Inc.
    Burlington, Massachusetts 01805, United States
  • University of Buffalo Neurosurgery (UBNS)
    Buffalo, New York 14203, United States
  • StonyBrook
    Stony Brook, New York 11794-8122, United States
08

References and documents

Publications

  • Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, Thomas D; MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004 May 8;363(9420):1491-502. doi: 10.1016/S0140-6736(04)16146-1. PubMed 15135594 ↗
  • Rothwell PM, Goldstein LB. Carotid endarterectomy for asymptomatic carotid stenosis: asymptomatic carotid surgery trial. Stroke. 2004 Oct;35(10):2425-7. doi: 10.1161/01.STR.0000141706.50170.a7. Epub 2004 Aug 26. No abstract available. PubMed 15331794 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2014, a primary completion of Nov 2019 and a completion of Nov 2019. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 15, 2014
First posted
Apr 21, 2014
Start
Apr 2014
Primary completionActual
Nov 2019
CompletionActual
Nov 2019
Last update
Nov 26, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 26, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02118233
Lead sponsor
Lahey Clinic
Responsible party
Sponsor
First posted
Apr 21, 2014
Start date
Apr 2014
Primary completion
Nov 2019
Completion
Nov 2019
Last update
Nov 26, 2019

Study contacts

Zoher Ghogawala, MD
principal investigator · Lahey Clinic, Inc.

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion